Lipid- and polymer-based nanoparticle systems for the delivery of CRISPR/Cas9

被引：34

作者：

Ashok, Bhaargavi ^{[1
]}

Peppas, Nicholas A. ^{[1
,2
,3
,4
,5
]}

Wechsler, Marissa E. ^{[6
]}

机构：

[1] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA

[2] Univ Texas Austin, Inst Biomat Drug Delivery & Regenerat Med, Austin, TX 78712 USA

[3] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA

[4] Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA

[5] Univ Texas Austin, Dell Med Sch, Dept Surg & Perioperat Care, Austin, TX 78712 USA

[6] Univ Texas San Antonio, Dept Biomed Engn & Chem Engn, San Antonio, TX 78249 USA

来源：

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | 2021年 / 65卷

基金：

美国国家卫生研究院;

关键词：

Hydrogels; Nanoparticles; CRISPR; Genome editing; IN-VIVO; TARGETED DELIVERY; MESSENGER-RNA; T-CELLS; GENE; CARRIERS; CANCER; VITRO; DNA; CRISPR-CAS9;

D O I：

10.1016/j.jddst.2021.102728

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The discovery of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) genome editing systems and their applications in human health and medicine has heralded a new era of biotechnology. However, the delivery of CRISPR therapeutics is arguably the most difficult barrier to overcome for translation to in vivo clinical administration. Appropriate delivery methods are required to efficiently and selectively transport all gene editing components to specific target cells and tissues of interest, while minimizing off-target effects. To overcome this challenge, we discuss and critique nanoparticle delivery strategies, focusing on the use of lipid-based and polymeric-based matrices herein.

引用

页数：13

共 108 条

[1] Adams GP, 2001, CANCER RES, V61, P4750
[2] Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis
Akinc, A
Thomas, M
Klibanov, AM
Langer, R
[J]. JOURNAL OF GENE MEDICINE, 2005, 7 (05) : 657 - 663
[3] In utero gene editing for monogenic lung disease
Alapati, Deepthi
Zacharias, William J.
Hartman, Heather A.
Rossidis, Avery C.
Stratigis, John D.
Ahn, Nicholas J.
Coons, Barbara
Zhou, Su
Li, Hiaying
Singh, Kshitiz
Katzen, Jeremy
Tomer, Yaniv
Chadwick, Alexandra C.
Musunuru, Kiran
Beers, Michael F.
Morrisey, Edward E.
Peranteau, William H.
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (488)
[4] Cell-Type-Specific CRISPR/Cas9 Delivery by Biomimetic Metal Organic Frameworks
Alyami, Mram Z.
Alsaiari, Shahad K.
Li, Yanyan
Qutub, Somayah S.
Aleisa, Fajr A.
Sougrat, Rachid
Merzaban, Jasmeen S.
Khashab, Niveen M.
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2020, 142 (04) : 1715 - 1720
[5] Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond
Arvizo, Rochelle R.
Miranda, Oscar R.
Thompson, Michael A.
Pabelick, Christina M.
Bhattacharya, Resham
Robertson, J. David
Rotello, Vincent M.
Prakash, Y. S.
Mukherjee, Priyabrata
[J]. NANO LETTERS, 2010, 10 (07) : 2543 - 2548
[6] Bamrungsap S, 2012, NANOMEDICINE-UK, V7, P1253, DOI [10.2217/NNM.12.87, 10.2217/nnm.12.87]
[7] Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Banerjee, Amrita
Qi, Jianping
Gogoi, Rohan
Wong, Jessica
Mitragotri, Samir
[J]. JOURNAL OF CONTROLLED RELEASE, 2016, 238 : 176 - 185
[8] Applications of CRISPR technologies in research and beyond
Barrangou, Rodolphe
Doudna, Jennifer A.
[J]. NATURE BIOTECHNOLOGY, 2016, 34 (09) : 933 - 941
[9] Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?
Bear, Adham S.
Morgan, Richard A.
Cornetta, Kenneth
June, Carl H.
Binder-Scholl, Gwendolyn
Dudley, Mark E.
Feldman, Steven A.
Rosenberg, Steven A.
Shurtleff, Sheila A.
Rooney, Cliona M.
Heslop, Helen E.
Dotti, Gianpietro
[J]. MOLECULAR THERAPY, 2012, 20 (02) : 246 - 249
[10] Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, Elvin
Shen, Haifa
Ferrari, Mauro
[J]. NATURE BIOTECHNOLOGY, 2015, 33 (09) : 941 - 951

← 1 2 3 4 5 6 7 8 9 10 →